VITREJECT Trademark

Trademark Overview

On Friday, December 12, 2014, a trademark application was filed for VITREJECT with the United States Patent and Trademark Office. The USPTO has given the VITREJECT trademark a serial number of 86479545. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Monday, January 10, 2022. This trademark is owned by OCUJECT, LLC. The VITREJECT trademark is filed in the Medical Instrument Products category with the following description:

Injection device for pharmaceuticals
vitreject

General Information

Serial Number86479545
Word MarkVITREJECT
Filing DateFriday, December 12, 2014
Status701 - SECTION 8 - ACCEPTED
Status DateMonday, January 10, 2022
Registration Number5013656
Registration DateTuesday, August 2, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2015

Trademark Statements

Pseudo MarkVITRE JECT; VITRE INJECTION
Goods and ServicesInjection device for pharmaceuticals

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, December 18, 2014
Primary Code010
First Use Anywhere DateThursday, March 24, 2016
First Use In Commerce DateThursday, March 24, 2016

Trademark Owner History

Party NameOCUJECT, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressNEWPORT BEACH, CA 92660
Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressNewport Beach, CA 92660
Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressNewport Beach, CA 92660
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressNewport Beach, CA 92660

Trademark Events

Event DateEvent Description
Tuesday, December 16, 2014NEW APPLICATION ENTERED
Saturday, December 12, 2015SOU EXTENSION 1 FILED
Thursday, December 18, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 19, 2014NOTICE OF PSEUDO MARK E-MAILED
Wednesday, March 25, 2015ASSIGNED TO EXAMINER
Wednesday, April 1, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 29, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 19, 2015PUBLISHED FOR OPPOSITION
Tuesday, May 19, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 14, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, December 12, 2015SOU TEAS EXTENSION RECEIVED
Saturday, December 12, 2015SOU EXTENSION 1 GRANTED
Tuesday, May 24, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, August 2, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, June 10, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 15, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 24, 2016USE AMENDMENT FILED
Thursday, June 16, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 24, 2016STATEMENT OF USE PROCESSING COMPLETE
Sunday, June 26, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 28, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, January 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 5, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 5, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 5, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, August 2, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, August 2, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 3, 2021TEAS SECTION 8 RECEIVED
Monday, January 10, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, January 10, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, January 10, 2022NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, January 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

vitreject pharmaceuticals device injection